# | Title | Journal | Year | Citations |
---|
|
1 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision | World Journal of Biological Psychiatry | 2008 | 671 |
2 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance | World Journal of Biological Psychiatry | 2012 | 517 |
3 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders | World Journal of Biological Psychiatry | 2013 | 503 |
4 | Serum and plasma BDNF levels in major depression: A replication study and meta-analyses | World Journal of Biological Psychiatry | 2010 | 374 |
5 | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder | World Journal of Biological Psychiatry | 2013 | 351 |
6 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects | World Journal of Biological Psychiatry | 2013 | 349 |
7 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care | World Journal of Biological Psychiatry | 2007 | 344 |
8 | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression | World Journal of Biological Psychiatry | 2010 | 328 |
9 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder | World Journal of Biological Psychiatry | 2002 | 313 |
10 | The suicidal mind and brain: A review of neuropsychological and neuroimaging studies | World Journal of Biological Psychiatry | 2011 | 313 |
11 | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania | World Journal of Biological Psychiatry | 2009 | 304 |
12 | Tinnitus and depression | World Journal of Biological Psychiatry | 2011 | 273 |
13 | The Tutsi genocide and transgenerational transmission of maternal stress: epigenetics and biology of the HPA axis | World Journal of Biological Psychiatry | 2014 | 271 |
14 | Mode of action of agomelatine: Synergy between melatonergic and 5-HT2Creceptors | World Journal of Biological Psychiatry | 2011 | 264 |
15 | Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition | World Journal of Biological Psychiatry | 2017 | 245 |
16 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia | World Journal of Biological Psychiatry | 2005 | 244 |
17 | Melatonin in mood disorders | World Journal of Biological Psychiatry | 2006 | 233 |
18 | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the biological treatment of paraphilias | World Journal of Biological Psychiatry | 2010 | 226 |
19 | Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry | World Journal of Biological Psychiatry | 2018 | 222 |
20 | Consensus paper of the WFSBP Task Force on Biological Markers: Biological Markers in Depression | World Journal of Biological Psychiatry | 2007 | 220 |
21 | Assessment and management of agitation in psychiatry: Expert consensus | World Journal of Biological Psychiatry | 2016 | 220 |
22 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia | World Journal of Biological Psychiatry | 2006 | 200 |
23 | Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis | World Journal of Biological Psychiatry | 2018 | 193 |
24 | Set-shifting abilities, central coherence, and handedness in anorexia nervosa patients, their unaffected siblings and healthy controls: Exploring putative endophenotypes | World Journal of Biological Psychiatry | 2010 | 185 |
25 | Central coherence in eating disorders: An updated systematic review and meta-analysis | World Journal of Biological Psychiatry | 2014 | 180 |
26 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Eating Disorders | World Journal of Biological Psychiatry | 2011 | 175 |
27 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015 | World Journal of Biological Psychiatry | 2015 | 164 |
28 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Bipolar Disorders, Part I: Treatment of Bipolar Depression | World Journal of Biological Psychiatry | 2002 | 163 |
29 | The insular Lobe of Reil–its Anatamico-Functional, behavioural and Neuropsychiatric attributes in humans–a review | World Journal of Biological Psychiatry | 2004 | 160 |
30 | Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics | World Journal of Biological Psychiatry | 2016 | 158 |
31 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders | World Journal of Biological Psychiatry | 2002 | 156 |
32 | The World Federation of Socleties of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania | World Journal of Biological Psychiatry | 2003 | 150 |
33 | Amniotic fluid inflammatory cytokines: Potential markers of immunologic dysfunction in autism spectrum disorders | World Journal of Biological Psychiatry | 2013 | 146 |
34 | Accelerated HF-rTMS in treatment-resistant unipolar depression: Insights from subgenual anterior cingulate functional connectivity | World Journal of Biological Psychiatry | 2014 | 146 |
35 | Do CSF total tau, phosphorylated tau, and β-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature | World Journal of Biological Psychiatry | 2008 | 143 |
36 | Social reward and rejection sensitivity in eating disorders: An investigation of attentional bias and early experiences | World Journal of Biological Psychiatry | 2013 | 143 |
37 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Personality Disorders | World Journal of Biological Psychiatry | 2007 | 140 |
38 | Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders | World Journal of Biological Psychiatry | 2007 | 134 |
39 | Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood–brain barrier integrity | World Journal of Biological Psychiatry | 2012 | 133 |
40 | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder | World Journal of Biological Psychiatry | 2018 | 133 |
41 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance Treatment of Major Depressive Disorder and Treatment of Chronic Depressive Disorders and Subthreshold Depressions | World Journal of Biological Psychiatry | 2002 | 132 |
42 | Abnormal body perception and neural activity in the insula in depression: An fMRI study of the depressed “material me” | World Journal of Biological Psychiatry | 2010 | 129 |
43 | Molecular genetic overlap in bipolar disorder, schizophrenia, and major depressive disorder | World Journal of Biological Psychiatry | 2014 | 125 |
44 | Management of mild cognitive impairment (MCI): The need for national and international guidelines | World Journal of Biological Psychiatry | 2020 | 125 |
45 | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part III: Maintenance Treatment | World Journal of Biological Psychiatry | 2004 | 124 |
46 | Biological markers for anxiety disorders, OCD and PTSD – a consensus statement. Part I: Neuroimaging and genetics | World Journal of Biological Psychiatry | 2016 | 122 |
47 | Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment | World Journal of Biological Psychiatry | 2010 | 119 |
48 | Stress Hormone-Related Psychopathology: Pathophysiological and Treatment Implications | World Journal of Biological Psychiatry | 2001 | 118 |
49 | Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: Impact of past episodes | World Journal of Biological Psychiatry | 2006 | 117 |
50 | Pro-inflammatory biomakers in depression: Treatment with venlafaxine | World Journal of Biological Psychiatry | 2009 | 116 |